DISCLAIMER: FOR RESEARCH USE ONLY. The material provided is "as is", and using TOPOGRAPH is without warranties of any kind, either expressed or implied. The content provided by this resource CANNOT subsitute for clinical judgement or professional oncology advice. Improper use of this resource may lead to harm.
NOTE: The haematology contents of this resource is currently under review and in the process of being updated.
Cabozantinib(AXL/MET/RET/VEGFR/ROS1/KIT inhibitor, AXL inhibitor, MET inhibitor, type 2, RET inhibitor, VEGFR2 inhibitor, ROS1 inhibitor, KIT inhibitor)